Heterologously type IV pilus expressed protein of Burkholderia Pseudomallei is immunogenic but fails to induce protective immunity in mice

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 5, 2011, Pages 1190-1196

  Sangdee, Kusavadee ^a   Waropastrakul, Srivilai ^a   Wongratanachewin, Surasak ^a   Homchampa, Preecha ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Burkholderia pseudomallei; PilV protein; Subunit vaccine; Type IV pili

Indexed keywords

EID: 80053077445     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
2. Breitbach K, Kçhler J, Steinmetz I. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Trans R Soc Trop Med Hyg 2008; 102 (suppl): S89-94.
3. Chen YS, Hsiao YS, Lin HH, Yen CM, Chen SC, Chen YL. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 2006; 24: 750-8.
4. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18: 383-416.
5. Elleman TC, Stewart DJ. Efficacy against footrot of a Bacteroides nodosus 265 (serogroup H) pilus vaccine expressed in Pseudomonas aeruginosa. Infect Immun 1988; 56: 595-600.
6. Essex-Lopresti AE, Boddey JA, Thomas R, et al. A type IV pilin, PilA, contributes to adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun 2005; 73: 1260-4.
7. Fernandes PJ, Guo Q, Waag DM, Donnenberg MS. The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model. Infect Immun 2007; 75: 3027-32.
8. Hara Y, Mohamed R, Nathan S. Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS One 2009, 4: e6496.
9. Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PC. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 2002; 51: 1055-62.
10. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8: 223-46.
11. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11: 413-25.
12. Lepper AW, Moore LJ, Atwell JL, Tennent JM. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. Vet Microbiol 1992; 32: 177-87.
13. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-73.
14. Moore RJ, Lenghaus C, Sheedy SA, Doran TJ. Improved vectors for expression library immunization-application to Mycoplasma hyopneumoniae infection in pigs. Vaccine 2001; 20: 115-20.
15. Sprague LD, Neubauer H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 2004; 51: 305-20.
16. Srilunchang T, Proungvitaya T, Wongratanacheewin S, Strugnell RA, Homchampa P. Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2. Southeast Asian J Trop Med Public Health 2009; 40: 123-30.
17. Su YC, Wan KL, Mohamed R, Nathan S. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Vaccine 2010; 28: 5005-11.
18. Tramont EC, Sadoff JC, Boslego JW, et al. Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest 1981; 68: 881-8.
19. Warawa J, Woods DE. Melioidosis vaccines. Expert Rev Vaccines 2002; 1: 477-82.
20. White NJ. Melioidosis. Lancet 2003; 361: 1715-22.
21. Winther-Larsen HC, Hegge FT, Wolfgang M, Hayes SF, van Putten JP, Koomey M. Neisseria gonorrhoeae PilV, a type IV pilus-associated protein essential to human epithelial cell adherence. Proc Natl Acad Sci USA 2001; 98: 15276-81.